US Ends Use of Vaccine Ingredient Targeted by Anti-Vaccine Movements

The US has decided to end the use of thimerosal, a preservative once targeted by anti-vaccine groups, after scientific reviews confirmed its safety, aiming to improve vaccine confidence.
The United States health authorities have announced the discontinuation of a vaccine ingredient that has long been the focus of anti-vaccine conspiracy theories. This decision comes after substantial scientific studies and expert reviews confirmed the safety of the ingredient, which was falsely believed by some groups to cause autism and other health problems.
The ingredient in question is thimerosal, a preservative used to prevent bacterial and fungal contamination in multidose vaccine vials. Extensive research, including assessments by the World Health Organization, has shown that thimerosal does not pose any health risk. Despite this, it has been a target of misinformation, prompting the CDC and other health organizations to reassess its use.
Following a recent panel review convened by vaccine advocate Robert F. Kennedy Jr., experts recommended phasing out thimerosal in influenza vaccines used for children, pregnant women, and adults. Earlier, the FDA had already limited the use of thimerosal in many vaccines available in the US. However, the new policy is seen as a step to address public concerns and combat vaccine hesitancy fueled by misinformation.
The move reflects broader efforts to bolster vaccine confidence and ensure public health safety. Health officials emphasize that vaccines are rigorously tested for safety and efficacy, and the removal of a preservative that is widely regarded as safe is unlikely to impact vaccine protection. Experts warn that continued misinformation can harm vaccination efforts, but committing to transparent and evidence-based policies remains key.
For more detailed insights, visit: https://medicalxpress.com/news/2025-07-vaccine-ingredient-anti-vaxxers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Bacterial Virus-Based Therapy Offers Hope for Genetic Diseases
A novel bacterial virus-based gene delivery system shows promise in revolutionizing treatment for inherited genetic diseases, offering cost-effective and personalized solutions.
Minimal Health Risks from Inactive H5N1 Virus in Pasteurized Milk Confirmed by Recent Research
Recent research confirms that inactivated H5N1 influenza virus in pasteurized milk poses minimal health risks, reinforcing the importance of proper milk pasteurization during outbreaks.
Innovative Microsensing Technology for Real-Time Monitoring of Cancer Progression
A new microsensing technology utilizing electrical impedance spectroscopy enables real-time, noninvasive tracking of cancer cell dynamics, offering promising advancements in cancer diagnosis and treatment.
Key Metric Identified to Improve Focused Ultrasound Treatment for High-Grade Gliomas
New research identifies a vital acoustic emission dose metric that could improve the safety and effectiveness of focused ultrasound treatments for brain tumors, enabling better drug delivery through the blood-brain barrier.